Comparison

TT-232 TFA(147159-51-1 free base) European Partner

Item no. TMO-T23479L-100mg
Manufacturer TargetMol
CASRN 2703745-48-4
Amount 100mg
Category
Type Molecules
Specific against other
Purity 99.80%
Citations Vantus T, Csermely P, Teplan I, Keri G. The tumor-selective somatostatin analog, TT2-32 induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620. Tumour Biol. 1995;16(4):261-267.
Smiles C[C@H]([C@@H](C(N)=O)NC([C@@H]1CSSC[C@@H](C(N[C@H](C(N[C@@H](C(N[C@H](C(N1)=O)CCCCN)=O)Cc(c[nH]2)c3c2cccc3)=O)Cc4ccc(O)cc4)=O)NC([C@@H](Cc5ccccc5)N)=O)=O)O.C(=O)(C(F)(F)F)O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias T23479L
Available
Short Description
TT2-32 TFA induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620
Shipping
cool pack
Storage
-20°
Molecular Weight
1061, 16

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close